They found that IDH-mutant gliomas exhibit fewer tumor infiltrating lymphocytes (TILs) and show reduced expression of programmed death ligand 1 (PD-L1) protein compared to that in the wild-type counterparts, which may be at least in part due to differential PD-L1 gene promoter methylation levels (15). Here, IDH1 is linked to glioma.